Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Regulation topic
No spam. Unsubscribe anytime.
Committee advances bill imposing safety and ethical standards on stem-cell therapy
Summary
House Health advanced HB2246 after the sponsor said the bill would establish medical and ethical guardrails for stem cell therapy, including prohibitions on embryonic sources and requirements for reporting viability and storage safety.
Representatives told the House Health Committee HB2246 sets standards intended to protect patients seeking stem-cell treatments in Tennessee. The sponsor said the bill was developed with multiple stem-cell therapy providers, the Tennessee Medical Association and Vanderbilt and would require cell viability reporting, storage safety measures, and prohibit use of embryos from aborted fetuses in therapies.
The sponsor argued the bill balances patient access with safety and transparency, saying Tennessee needs clear rules because stem-cell therapy practices have been largely unregulated. Committee members expressed support and the bill passed out of committee (19-0) to government operations as amended.
